Interestingly, selective GluN2B receptor antagonism was found to alleviate symptoms in rodent and primate models of PD [58,59,60,61,62], suggesting an important role of GluN2B-mediated signaling in PD. The gene discussed is GRIN2B; the disease is Parkinson disease.